Skip to main content

Netherlands

26
Oct 2022

Dutch Healthcare Authority published the second release of the 2023 DRG package

On September 22, 2022, the Dutch Healthcare Authority (NZa) published the second release of the DRG package for 2023 (RZ23b). Nineteen new procedure codes, eight new supplementary payments, and seven new DRGs will be implemented. These changes concern remote monitoring, molecular diagnostics, surgical procedures, gynecology and dermatology technology groups.
18
Oct 2022

Three projects awarded under the 2022 "Subsidy scheme for promising care" in the Netherlands

In September 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three more projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of PET/CT scan instead of CT scan for post-screening in lung cancer, treatment for head and neck cancer that spares lymph nodes in the neck and surgery to prevent lymphedema after cancer treatment. In total, eight projects will receive a subsidy in 2022.
25
Mar 2022

Three projects awarded under the 2022 "Subsidy scheme for promising care" in the Netherlands

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.
17
Jan 2022

Dutch Healthcare Authority published draft release of the DRG package for 2023

Dutch Healthcare Authority (NZa) has issued a draft release of the DRG package for 2023, including a new procedure code for intermittent pneumatic compression therapy, a new diagnosis code for guidance in early pregnancy after a fertility program, and several new DRGs for pediatric palliative care, lymphovenous anastomosis surgery and light therapy in inflammatory dermatoses.